Lymphastat V Liquid
NDC Package 44911-0622-1
Package Information
Lymphastat V (echinacea (angustifolia), lomatium dissectum, hydrastis canadensis, aconitum napellus, arsenicum album, belladonna, eupatorium perfoliatum, gelsemium sempervirens, lachesis mutus, rhus tox, pyrogenium) liquids May temporarily relieve symptoms associated with viral infections, such as fever, rash, and achiness.****Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0622.
Identification & Billing
Clinical Specifications
- ACONITUM NAPELLUS WHOLE 12 [hp_X]/mL
- ARSENIC TRIOXIDE 12 [hp_X]/mL
- ATROPA BELLADONNA 12 [hp_X]/mL
- ECHINACEA ANGUSTIFOLIA WHOLE 3 [hp_X]/mL
- EUPATORIUM PERFOLIATUM FLOWERING TOP 12 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X]/mL
- GOLDENSEAL 6 [hp_X]/mL
- LACHESIS MUTA VENOM 12 [hp_X]/mL
- LOMATIUM DISSECTUM ROOT 3 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 12 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0622 - Lymphastat V
- 44911-0622-1 - 60 mL in 1 BOTTLE, DROPPER
- 44911-0622 - Lymphastat V
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0622-1 identifies a specific commercial package of 60 ml in 1 bottle, dropper of Lymphastat V, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains aconitum napellus whole; arsenic trioxide; atropa belladonna; echinacea angustifolia whole; eupatorium perfoliatum flowering top; gelsemium sempervirens root; goldenseal; lachesis muta venom; lomatium dissectum root; toxicodendron pubescens leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on May 24, 2021.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911062201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.